IMN || Women's Health

Sexually transmitted infections missed as UTIs are overdiagnosed

Posted on: 26/06/2015 - 18:54

Women may be receiving unnecessary antibiotics for overdiagnosed urinary tract infections while their sexually transmitted infections go undetected, according to a recent study in an urban academic...

Field of Interest: Pulmonology

Type: News Item

FDA advisors urge physician certification for flibanserin

Posted on: 23/06/2015 - 19:24

Without the option of recommending physician certification as a condition for flibanserin approval, the Food and Drug Administration advisory panel vote might have shifted against approval of the...

Field of Interest: Pulmonology

Type: News Item

Pregnancy outcomes better than expected in SLE

Posted on: 22/06/2015 - 22:00

Pregnancy outcomes in women with systemic lupus erythematosus were better than expected in the largest study of the issue to date, according to a report published online June 22 in Annals of Internal...

Field of Interest: Pulmonology

Type: News Item

Pregnancy outcomes better than expected in SLE

Posted on: 22/06/2015 - 22:00

Field of Interest: Rheumatology

Type: News Item

Insurance, location, income drive breast cancer surgery choices

Posted on: 17/06/2015 - 18:34

The rates of breast-conserving surgery have increased over the last 2 decades among women with early-stage breast cancers in the United States, but disparities persist, based on an analysis of data...

Field of Interest: Oncology

Type: News Item

Insurance, location, income drive breast cancer surgery choices

Posted on: 17/06/2015 - 18:34

Field of Interest: Pulmonology

Type: News Item

Q&A with the FDA: Implementing the Pregnancy and Lactation Labeling Rule

Posted on: 15/06/2015 - 18:56

On June 30, pharmaceutical and biological manufacturers will begin implementing the Food and Drug Administration’s revised rules for pregnancy and lactation drug labeling. The Pregnancy and Lactation...

Field of Interest: Pulmonology

Type: News Item

ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs

Posted on: 10/06/2015 - 23:01

CHICAGO – Adjuvant denosumab is efficacious and safe for reducing fracture risk among women taking aromatase inhibitors (AIs) as part of their treatment for early breast cancer, finds the Austrian...

Field of Interest: Oncology

Type: News Item

ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs

Posted on: 10/06/2015 - 23:01

Field of Interest: Pulmonology

Type: News Item

Women’s acne mirrors teen acne

Posted on: 28/05/2015 - 18:34

The distribution of acne lesions in adults is similar to that in adolescents, based on data from a prospective study of 374 women aged 25 years and older. “The stereotype of adult female acne being...

Field of Interest: Pulmonology

Type: News Item

Sexually transmitted infections missed as UTIs are overdiagnosed

FDA advisors urge physician certification for flibanserin

Pregnancy outcomes better than expected in SLE

Pregnancy outcomes better than expected in SLE

Insurance, location, income drive breast cancer surgery choices

Insurance, location, income drive breast cancer surgery choices

Q&A with the FDA: Implementing the Pregnancy and Lactation Labeling Rule

ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs

ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs

Women’s acne mirrors teen acne

Newsletters

Latest Newsletters

You are here

IMN || Women's Health

Newsletters

Latest Newsletters